National Institute of Environmental Health Sciences; Notice of Meeting, 18769 [2011-8048]

Download as PDF Federal Register / Vol. 76, No. 65 / Tuesday, April 5, 2011 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Meeting srobinson on DSKHWCL6B1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Interagency Breast Cancer and Environmental Research Coordinating Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below at least 10 days in advance of the meeting. Name of Committee: Interagency Breast Cancer and Environmental Research Coordinating Committee (IBCERC). Date: May 12–13, 2011. Time: 8:30 a.m. to 5:30 p.m. Agenda: The purpose of the meeting is to continue the work of the Committee, which is to share and coordinate information on existing research activities, and to make recommendations to the National Institutes of Health and other Federal agencies regarding how to improve existing research programs related to breast cancer and the environment. In advance of the meeting, the agenda will be posted on the Web at https://www.niehs.nih.gov/about/orgstructure/ boards/ibcercc/. Place: National Institute of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709. Contact Person: Gwen W. Collman, PhD, Director, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, 615 Davis Dr., KEY615/3112, Research Triangle Park, NC 27709. (919) 541–4980. collman@niehs.nih.gov. Any member of the public interested in presenting oral comments to the committee should submit their remarks in writing at least 10 days in advance of the meeting. Comments in document format (i.e. WORD, Rich Text, PDF) may be submitted via e-mail to ibcercc@niehs.nih.gov or mailed to the Contact Person listed on this notice. You do not need to attend the meeting in order to submit comments. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral comments you wish to present. Only one representative per organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. The statement should include the name, address, telephone number and, when VerDate Mar<15>2010 18:30 Apr 04, 2011 Jkt 223001 applicable, the business or professional affiliation of the interested person. Oral comments will begin at approximately 4 p.m. on Friday, May 13, 2011. Anyone who wishes to attend the meeting and/or submit comments to the committee is asked to RSVP via the following e-mail: ibcercc@niehs.nih.gov. All comments are delivered to the Contact Person listed on this notice. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances— Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: March 28, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–8048 Filed 4–4–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Prospective Grant of Exclusive License: Device and System for Two Dimensional Analysis of Biomolecules From Tissue and Other Samples National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in PCT Patent Application No. PCT/US03/37208 [HHS Ref. No. E– 339–2002/0–PCT–02], filed November 20, 2003, which published as WO 2004/ 048928 on June 10, 2004, now expired, entitled ‘‘Method And Apparatus for Performing Multiple Simultaneous Manipulations of Biomolecules In a Two-Dimensional Array;’’ U.S. Patent Application No. 10/535,521 [HHS Ref. No. E–339–2002/0–US–03], filed May 18, 2005, now abandoned, which published as US–2006–0147926 A1 on July 6, 2006 entitled ‘‘Method And Apparatus for Performing Multiple Simultaneous Manipulations of Biomolecules In a Two-Dimensional Array;’’ U.S. Patent Application No. 12/ 587,976 [HHS Ref. No. E–339–2002/0– SUMMARY: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 18769 US–04], filed October 14, 2009, which published as US–2010–010506 on April 29, 2010 entitled ‘‘Device for External Movement Manipulation of Nucleic Acids and/or Proteins;’’ U.S. Provisional Patent Application No. 61/206,458 [HHS Ref. No. E–130–2006/0–US–01] filed January 30, 2009, entitled, ‘‘Amplification Platform and Methods of Use Thereof, now expired, and PCT Patent Application No. PCT/US10/ 022586 [HHS Ref. No. E–130–2006/0– PCT–02] filed January 29, 2010 and which published as WO 2010/088517 on August 5, 2010, entitled, ‘‘Methods and Systems for Purifying, Transferring and/or Manipulating Nucleic Acids;’’ and all continuing applications and foreign counterparts to 2–D Bio, LLC, having a place of business in Gaithersburg, Maryland. The patent rights in these inventions have been assigned to the United States of America. However, the patent rights for HHS Ref. No. E–130–2006/0–US–01 and HHS Ref. No. E–130–2006/0–PCT–02 are co-owned and co-assigned to the University of Maryland. The United States of America has obtained an exclusive license to the University of Maryland’s rights in the invention. The prospective exclusive license territory may be ‘‘worldwide’’, and the field of use may be limited to ‘‘development of devices for sale and services for high throughput parallel analysis and two dimensional analyses of molecules for all uses.’’ DATES: Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before May 5, 2011 will be considered. ADDRESSES: Requests for copies of the patent application, inquiries, comments, and other materials relating to the contemplated exclusive license should be directed to: Kevin W. Chang, PhD, Senior Licensing and Patenting Manager, Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852–3804; Telephone: (301) 435–5018; Facsimile: (301) 402– 0220; E-mail: changke@mail.nih.gov. SUPPLEMENTARY INFORMATION: The subject technologies are methods, systems, and devices for purifying, transferring, or manipulating biomolecules, including nucleic acids from a sample, or performing a combination thereof, that substantially preserve two-dimensional (2D) spatial information on the original locations of the biomolecules within the sample. The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. E:\FR\FM\05APN1.SGM 05APN1

Agencies

[Federal Register Volume 76, Number 65 (Tuesday, April 5, 2011)]
[Notices]
[Page 18769]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8048]



[[Page 18769]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Environmental Health Sciences; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Interagency Breast Cancer and Environmental Research Coordinating 
Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should inform the Contact Person listed below at least 
10 days in advance of the meeting.

    Name of Committee: Interagency Breast Cancer and Environmental 
Research Coordinating Committee (IBCERC).
    Date: May 12-13, 2011.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: The purpose of the meeting is to continue the work of 
the Committee, which is to share and coordinate information on 
existing research activities, and to make recommendations to the 
National Institutes of Health and other Federal agencies regarding 
how to improve existing research programs related to breast cancer 
and the environment. In advance of the meeting, the agenda will be 
posted on the Web at https://www.niehs.nih.gov/about/orgstructure/boards/ibcercc/.
    Place: National Institute of Environmental Health Sciences, 
Building 101, Rodbell Auditorium, 111 T.W. Alexander Drive, Research 
Triangle Park, NC 27709.
    Contact Person: Gwen W. Collman, PhD, Director, Division of 
Extramural Research and Training, National Institute of 
Environmental Health Sciences, 615 Davis Dr., KEY615/3112, Research 
Triangle Park, NC 27709. (919) 541-4980. collman@niehs.nih.gov.

    Any member of the public interested in presenting oral comments 
to the committee should submit their remarks in writing at least 10 
days in advance of the meeting. Comments in document format (i.e. 
WORD, Rich Text, PDF) may be submitted via e-mail to 
ibcercc@niehs.nih.gov or mailed to the Contact Person listed on this 
notice. You do not need to attend the meeting in order to submit 
comments.
    Interested individuals and representatives of organizations may 
submit a letter of intent, a brief description of the organization 
represented, and a short description of the oral comments you wish 
to present. Only one representative per organization may be allowed 
to present oral comments and if accepted by the committee, 
presentations may be limited to five minutes. Both printed and 
electronic copies are requested for the record. The statement should 
include the name, address, telephone number and, when applicable, 
the business or professional affiliation of the interested person. 
Oral comments will begin at approximately 4 p.m. on Friday, May 13, 
2011. Anyone who wishes to attend the meeting and/or submit comments 
to the committee is asked to RSVP via the following e-mail: 
ibcercc@niehs.nih.gov. All comments are delivered to the Contact 
Person listed on this notice.

(Catalogue of Federal Domestic Assistance Program Nos. 93.115, 
Biometry and Risk Estimation Health Risks from Environmental 
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety 
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic 
Research and Education; 93.894, Resources and Manpower Development 
in the Environmental Health Sciences; 93.113, Biological Response to 
Environmental Health Hazards; 93.114, Applied Toxicological Research 
and Testing, National Institutes of Health, HHS)

    Dated: March 28, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-8048 Filed 4-4-11; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.